Douglas E. Williams - Apr 10, 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & President, R&D
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Douglas E. Williams
Stock symbol
SANA
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
4
Date filed
4/11/2023, 04:26 PM
Previous filing
Mar 30, 2023
Next filing
Nov 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +1.1M $0.00 1.1M Apr 10, 2023 Common Stock 1.1M $3.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% of the underlying shares on April 10, 2024 and in 36 equal monthly installments thereafter.